BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17482246)

  • 1. Zonisamide decreases ethanol intake in rats and mice.
    Knapp CM; Mercado M; Markley TL; Crosby S; Ciraulo DA; Kornetsky C
    Pharmacol Biochem Behav; 2007 May; 87(1):65-72. PubMed ID: 17482246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
    Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C
    J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice.
    Gabriel KI; Cunningham CL
    Alcohol Clin Exp Res; 2005 Jan; 29(1):75-80. PubMed ID: 15654294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of topiramate treatment on ethanol consumption in rats.
    Breslin FJ; Johnson BA; Lynch WJ
    Psychopharmacology (Berl); 2010 Jan; 207(4):529-34. PubMed ID: 19823810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats.
    Hargreaves GA; McGregor IS
    Alcohol Clin Exp Res; 2007 Nov; 31(11):1900-7. PubMed ID: 17877781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats.
    Zalewska-Kaszubska J; Bajer B; Gorska D; Andrzejczak D; Dyr W; Bieńkowski P
    Psychopharmacology (Berl); 2013 Jan; 225(2):275-81. PubMed ID: 22847457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmaco-EEG-based assessment of the interaction between ethanol and zonisamide.
    Pietrzak B; Zwierzyńska E; Krupa A
    Alcohol Alcohol; 2014; 49(5):505-14. PubMed ID: 24936587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse.
    Lynch WJ; Bond C; Breslin FJ; Johnson BA
    Psychopharmacology (Berl); 2011 Sep; 217(1):3-12. PubMed ID: 21424693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate, zonisamide and weight loss in children and adolescents prescribed psychiatric medications: A medical record review.
    Shapiro M; Reid A; Olsen B; Taasan M; McNamara J; Nguyen M
    Int J Psychiatry Med; 2016; 51(1):56-68. PubMed ID: 26681236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate reduces ethanol consumption by C57BL/6 mice.
    Nguyen SA; Malcolm R; Middaugh LD
    Synapse; 2007 Mar; 61(3):150-6. PubMed ID: 17146766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes.
    Navarrete F; Rubio G; Manzanares J
    Addict Biol; 2014 Sep; 19(5):862-73. PubMed ID: 23573810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers.
    Sarid-Segal O; Knapp CM; Burch W; Richardson MA; Bahtia S; DeQuattro K; Afshar M; Richambault C; Sickels L; Devine E; Ciraulo DA
    Am J Drug Alcohol Abuse; 2009; 35(5):316-9. PubMed ID: 19637104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin.
    Yamamura S; Hamaguchi T; Ohoyama K; Sugiura Y; Suzuki D; Kanehara S; Nakagawa M; Motomura E; Matsumoto T; Tanii H; Shiroyama T; Okada M
    Epilepsy Res; 2009 Apr; 84(2-3):172-86. PubMed ID: 19268540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.
    Lidö HH; Marston H; Ericson M; Söderpalm B
    Addict Biol; 2012 Sep; 17(5):897-907. PubMed ID: 21955180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effect of doxasozin and zonisamide on voluntary ethanol intake in mice that experienced chronic intermittent ethanol exposure and stress.
    Lopez MF; Reasons SE; Carper BA; Nolen TL; Williams RL; Becker HC
    Alcohol; 2020 Dec; 89():37-42. PubMed ID: 32712186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.
    Moore CF; Protzuk OA; Johnson BA; Lynch WJ
    Pharmacol Biochem Behav; 2014 Jan; 116():107-15. PubMed ID: 24252444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol intake decreases brain Zonisamide concentration in inbred EL mice.
    Nagatomo I; Akasaki Y; Uchida M; Takigawa M
    Neuroreport; 1997 Jan; 8(2):391-4. PubMed ID: 9080413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against a significant implication of carbonic anhydrase inhibitory activity of zonisamide in its anticonvulsive effects.
    Masuda Y; Noguchi H; Karasawa T
    Arzneimittelforschung; 1994 Mar; 44(3):267-9. PubMed ID: 8192690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voluntary ethanol consumption decreases after the inactivation of central acetaldehyde by d-penicillamine.
    Font L; Aragon CM; Miquel M
    Behav Brain Res; 2006 Jul; 171(1):78-86. PubMed ID: 16621047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats.
    Schroeder JP; Overstreet DH; Hodge CW
    Alcohol; 2005 Jul; 36(3):179-86. PubMed ID: 16377459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.